Melbourne: Telix Pharmaceuticals Limited (ASX: TLX) launched its initial public offering in the United States of AmericanDepositary Shares (ADSs), each representing one ordinary share in Telix. The target size of the offering is US$200 million in gross proceeds. In addition, Telix expects to grant the Underwriters (asdefined below) a 30-day option to purchase up to…